Search - tctmd.com

Displaying 561 - 580 of 648

Sort: Relevancy | Date

Presentation TCT 2014

TAVR Is Preferred for All but the Lowest-Risk Patients!

Presenter: Alejandro O. Palacios, Ernesto M. Torresani, Alec S. Vahanian

September 13, 2014

Presentation TCT 2014

Surgery for All but the Highest-Risk Patients!

Presenter: Alejandro O. Palacios, Ernesto M. Torresani, Jose Navia

September 13, 2014

Presentation TCT 2014

TCT 689: Three- and Five-Year Outcomes after Transcatheter Aortic Valve Implantation in High-Risk Patients with Severe Aortic Stenosis: The U.K. TAVI (United Kingdom Aortic Valve Implantation) Registry

Presenter: Patrick W. Serruys, E. Murat Tuzcu, Ian T. Meredith, Alison Duncan

September 13, 2014

Presentation TCT 2014

Thoughtful Perspectives on the Futile Patient with Aortic Stenosis

Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Robert A. Guyton

September 13, 2014

Presentation TCT 2014

Important Changes in the New 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations

Presenter: A. Pieter Kappetein, Martin B. Leon, Howard C. Herrmann, Robert O. Bonow

September 13, 2014

Presentation TCT 2014

The CoreValve US Pivotal Trial: Two-Year Results with a Self-Expanding Bioprosthesis in Extremely High-Risk Patients with Aortic Stenosis

Presenter: Robert J. Applegate, Ronald Caputo, Steven J. Yakubov

September 13, 2014

Presentation TCT 2014

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Presenter: Patrick W. Serruys, David J. Cohen, Axel Linke

September 13, 2014

Presentation TCT 2014

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Matthew R. Reynolds

September 13, 2014

Presentation TCT 2014

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Samir R. Kapadia

September 13, 2014

Presentation TCT 2014

Hemodynamics of Aortic Stenosis and Live Calculations Using the Telestrator

Presenter: Thomas H. Maloney, John R. Zimmerman, Tim J. Lapp

September 13, 2014

News Conference News TCT 2014

TAVR Effective in High-Risk Patients at ‘Acceptable’ Cost

Todd Neale

September 13, 2014

News Conference News TCT 2014

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Yael L. Maxwell

September 13, 2014

News Conference News TCT 2014

Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices

September 13, 2014

News Conference News TCT 2014

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

September 13, 2014

News Conference News TCT 2013

TAVR a Viable Option for Intermediate-Risk Patients

November 05, 2013

Presentation TCT 2013

REPRISE II: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

Presenter: Ian Meredith

October 31, 2013

Presentation TCT 2013

Case #5 - Multivessel Disease and Aortic Stenosis: Therapy Selection and Sequence

Presenter: George Latsios

October 31, 2013

News Conference News TCT 2013

Second-Generation TAVR Device Overcomes Issues of Current Valves

October 31, 2013

Presentation TCT 2013

Case Presentation Introduction: A Low to Intermediate Risk Patient with Symptomatic Aortic Stenosis Who Doesn't Want Surgery

Presenter: Michael Mullen

October 30, 2013

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

Advertisement

TAVR Is Preferred for All but the Lowest-Risk Patients!

Surgery for All but the Highest-Risk Patients!

TCT 689: Three- and Five-Year Outcomes after Transcatheter Aortic Valve Implantation in High-Risk Patients with Severe Aortic Stenosis: The U.K. TAVI (United Kingdom Aortic Valve Implantation) Registry

Thoughtful Perspectives on the Futile Patient with Aortic Stenosis

Important Changes in the New 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations

The CoreValve US Pivotal Trial: Two-Year Results with a Self-Expanding Bioprosthesis in Extremely High-Risk Patients with Aortic Stenosis

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

Hemodynamics of Aortic Stenosis and Live Calculations Using the Telestrator

TAVR Effective in High-Risk Patients at ‘Acceptable’ Cost

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

TAVR a Viable Option for Intermediate-Risk Patients

REPRISE II: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

Case #5 - Multivessel Disease and Aortic Stenosis: Therapy Selection and Sequence

Second-Generation TAVR Device Overcomes Issues of Current Valves

Case Presentation Introduction: A Low to Intermediate Risk Patient with Symptomatic Aortic Stenosis Who Doesn't Want Surgery

Two Trials to Assess TAVR in Moderate-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content